Clinical Trials
4 trialsNCT02770378 2021-10-05
A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
University of Ulm
Phase 1/2 Completed
NCT01580969 2019-08-16
RAMBO
University of Utah
Phase 1/2 Completed
NCT01048983 2015-03-05
Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn
NCT01219673 2015-02-10
Symptom Burden in Head and Neck Cancer
M.D. Anderson Cancer Center
Phase 1/2 Terminated